141 related articles for article (PubMed ID: 35777306)
1. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries.
Stang A; Wellmann I; Holleczek B; Fell B; Terner S; Lutz MP; Kajüter H
Cancer Epidemiol; 2022 Aug; 79():102204. PubMed ID: 35777306
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany.
Nachtsheim L; Mayer M; Meyer MF; Oesterling F; Kajueter H; Arolt C; Quaas A; Klussmann JP; Wolber P
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3811-3821. PubMed ID: 35994118
[TBL] [Abstract][Full Text] [Related]
5. [Liver metastases: incidence and histogenesis].
Kasper HU; Drebber U; Dries V; Dienes HP
Z Gastroenterol; 2005 Oct; 43(10):1149-57. PubMed ID: 16220456
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
7. Survival in neuroendocrine neoplasms; A report from a large Norwegian population-based study.
Boyar Cetinkaya R; Aagnes B; Myklebust TÅ; Thiis-Evensen E
Int J Cancer; 2018 Mar; 142(6):1139-1147. PubMed ID: 29082524
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
9. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000-2014 (CONCORD-3).
Nikšić M; Matz M; Valkov M; Marcos-Gragera R; Stiller C; Rosso S; Coleman MP; Allemani C;
Cancer Epidemiol; 2022 Oct; 80():102196. PubMed ID: 35841761
[TBL] [Abstract][Full Text] [Related]
10. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.
Stemann Lau T; Dam G; Jepsen P; Grønbæk H; Krogh K; Gregersen T
Neuroendocrinology; 2018; 107(3):280-283. PubMed ID: 30092588
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
12. Incidence of testicular tumor subtypes according to the updated WHO classification, North Rhine-Westphalia, Germany, 2008-2013.
Stang A; Rusner C; Trabert B; Oosterhuis JW; McGlynn KA; Heidinger O
Andrology; 2019 Jul; 7(4):402-407. PubMed ID: 30578617
[TBL] [Abstract][Full Text] [Related]
13. Differences in site-specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007-2015.
Stang A; Wellmann I; Kajüter H; Trocchi P; Becker JC; Green AC; Jöckel KH; Khil L
Int J Cancer; 2020 Nov; 147(10):2772-2779. PubMed ID: 32445192
[TBL] [Abstract][Full Text] [Related]
14. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
15. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.
Caldarella A; Crocetti E; Paci E
Pathol Oncol Res; 2011 Sep; 17(3):759-63. PubMed ID: 21476126
[TBL] [Abstract][Full Text] [Related]
16. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Cancer Med; 2018 Nov; 7(11):5775-5788. PubMed ID: 30264519
[TBL] [Abstract][Full Text] [Related]
17. Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study.
Albores-Saavedra J; Hart A; Chablé-Montero F; Henson DE
Arch Pathol Lab Med; 2010 Nov; 134(11):1692-6. PubMed ID: 21043824
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.
Alsina M; Marcos-Gragera R; Capdevila J; Buxó M; Ortiz RM; Barretina P; Vilardell L; Brunet J; Beltran M; Izquierdo Á
Cancer Epidemiol; 2011 Dec; 35(6):e49-54. PubMed ID: 21840785
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
[TBL] [Abstract][Full Text] [Related]
20. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.
van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T;
Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]